Cassava Sciences Inc (SAVA)

NASDAQ HEALTHCARE
$2.38 +0.00% RSI 60 Neutral Add Alert

Moving Averages

SMA 200
$2.52
Price below

Company Profile

Cassava Sciences, Inc., a clinical-stage biotechnology company, develops drugs for neurodegenerative diseases. The company is headquartered in Austin, Texas.

Sector
HEALTHCARE
Industry
BIOTECHNOLOGY
Market Cap
$114.97M
P/E Ratio
None
EPS
$-2.22
Beta
-0.84
Dividend Yield
0.00%
52-Week High
$4.98
52-Week Low
$1.2

Similar stocks in BIOTECHNOLOGY

BNTX
BioNTech SE
RSI 44.0
VRTX
Vertex Pharmaceuticals Inc
RSI 50.0
CRSP
CRISPR Therapeutics AG
RSI 55.0
MRNA
Moderna Inc
RSI 41.0
VKTX
Viking Therapeutics Inc
RSI 48.0
SRPT
Sarepta Therapeutics Inc
RSI 44.0
EDIT
Editas Medicine Inc
RSI 59.0
IOVA
Iovance Biotherapeutics Inc
RSI 54.0
NVAX
Novavax Inc
RSI 60.0
DNA
Ginkgo Bioworks Holdings Inc - Class A
RSI 58.0

Data last updated: May 31, 2026 at 9:28 AM EDT

Track SAVA for free

Get e-mail RSI alerts when Cassava Sciences Inc enters oversold or overbought territory. Free forever.

Add Alert